NCT04003818View on ClinicalTrials.gov

Efficacy and Safety of Teicoplanin in CDAD

PHASE4TerminatedINTERVENTIONAL

Enrollment

50

Participants

Timeline

Start Date

May 15, 2020

Primary Completion Date

January 21, 2021

Study Completion Date

March 10, 2021

Conditions

Clostridium Difficile Infection-associated Diarrhea and Colitis

Interventions

DRUG

TEICOPLANIN

Pharmaceutical form:solution for oral administration Route of administration: oral

Trial Locations (1)

Unknown

investigational site CHINA, China

Sponsors

Lead Sponsor

All Listed Sponsors

lead

Sanofi

INDUSTRY